During the early days of the pandemic, former NIH Director Dr. Francis Collins became a familiar voice steering the country through an unprecedented public health crisis.

Now, he is going through his own health crisis, an aggressive form of prostate cancer. By talking about it publicly he hopes to draw attention to routine screening.

For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org.

Email us at considerthis@npr.org.

Dr. Henry Marsh felt comfortable in hospitals — until he was diagnosed with advanced prostate cancer. "I was much less self-assured now that I was a patient myself," he says. His book is And Finally.

Lupron, a drug patented half a century ago, treats advanced prostate cancer. It costs a few hundred dollars in the U.K. — so why are U.S. hospitals charging so much more to administer it?